Today, I oversee $2B+ in global spend influencing revenue across the full pharmaceutical lifecycle, from early research through commercial manufacturing. With a global team, the team's remit spans scientific enablement, CDMO strategy, supply continuity, cost structure design, and working capital optimization.  Procurement, at scale, is not about price compression. It is about architecting financial resilience, aligning external ecosystems to enterprise strategy, and building optionality in uncertain environments.  I believe modern procurement must integrate commercial, R&D, operations, and finance, acting as a strategic integrator across the organization.